← Back to All Stocks

Biomea Fusion, Inc. (BMEA) Analysis

Generated on: 2025-06-28 17:46:14 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.

Analysis Values

Current Price
$1.69
Predicted Price
$2.26
Expected Return
16.59%
Confidence Score
0.83
RSI (14)
38.11
MACD
-0.01
Volume
4,507,500
Float Shares
29,253,754
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
250

BMEA

Biomea Fusion, Inc.
16.59%
Price: $1.69
Confidence: 0.83
News
Low Float
Last updated: 2025-06-28 17:46:14

Technical Analysis

RSI: 38.11
MACD: -0.01
Technical Analysis Graph

Risk Analysis

Volatility
114.28%
Max Drawdown
-88.8%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Biomea Fusion announces presentation of icovamenib preclinical, clinical data
TipRanks - 2025-06-24 17:07
Biomea Fusion (BMEA) announced the presentation of new preclinical and clinical data for icovamenib, the company’s investigational oral menin inhibitor, at the 85th Scientific Sessions of the American Diabetes Association June 20-23, 2025 in Chicago. Biomea presented three abstracts: one oral presentation and two posters, all highlighting icovamenib’s therapeutic potential across key dimensions of T2D pathophysiology, including its impact on beta cell restoration, and synergy with glucagon-like

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.